HLA-DRB1 and hepatocellular carcinoma: Plausible molecular mechanisms underlying the association between HLA alleles and HCC risk were inferred through in silico analysis of the binding of HLA-DRB1 to HBV-derived peptides, as well as the mutational and transcriptional profiles of 160 HCC tissue samples collected from Japanese patients.